Cite

HARVARD Citation

    Iwata, Y. et al. (2015). Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome. Bioorganic & medicinal chemistry letters. 25 (2), pp. 236-240. [Online]. 
  
Back to record